Drug eruption secondary to aciclovir with recall phenomenon in a dermatome previously affected by herpes zoster

被引:15
作者
Carrasco, L
Pastor, MA
Izquierdo, MJ
Fariña, MC
Martín, L
Fortes, J
Requena, L
机构
[1] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Dermatol, Madrid 28040, Spain
[2] Univ Autonoma Madrid, Fdn Jimenez Diaz, Dept Pathol, Madrid 28040, Spain
关键词
D O I
10.1046/j.1365-2230.2002.00990.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Classically, recall dermatitis refers to chemotherapy-induced reactivation of skin damage caused by radiotherapy months, or even years, earlier. The concept of recall dermatitis has now been extended to include radiation recall dermatitis induced by other drugs, ultraviolet radiation, extravasation of drugs, and allergic contact dermatitis. We now describe recall dermatitis along the residual cutaneous lesions of a previous thoracic herpes zoster in a patient who developed a drug eruption after oral administration of aciclovir. The most striking feature consisted of confluent linear erythema along the dermatomes previously involved by the herpes zoster episode. Histopathologic study demonstrated small foci of spongiosis, vacuolar changes involving the basal layer of the epidermis and single necrotic keratinocytes scattered within the epidermis. The papillary dermis appeared oedematous and with dilated blood capillaries surrounded by a sparse inflammatory infiltrate composed mainly of lymphocytes. Serial sections failed to demonstrate cytologic changes of herpes varicella zoster infection. We interpreted this case as an example of recall dermatitis because the widespread cutaneous eruption secondary to aciclovir was more intense in skin previously compromised by herpes varicella zoster infection. To the best of our knowledge, recall dermatitis has not been described before at the site of previous involvement by herpes zoster.
引用
收藏
页码:132 / 134
页数:3
相关论文
共 12 条
[1]   ACYCLOVIR HALTS PROGRESSION OF HERPES-ZOSTER IN IMMUNOCOMPROMISED PATIENTS [J].
BALFOUR, HH ;
BEAN, B ;
LASKIN, OL ;
AMBINDER, RF ;
MEYERS, JD ;
WADE, JC ;
ZAIA, JA ;
AEPPLI, D ;
KIRK, LE ;
SEGRETI, AC ;
KEENEY, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) :1448-1453
[2]  
BALFOUR HH, 1981, MINN MED, V64, P739
[3]   VESICULAR ERUPTIONS FOLLOWING ACYCLOVIR ADMINISTRATION [J].
BUCK, ML ;
VITTONE, SB ;
ZAGLUL, HF .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (12) :1458-1459
[4]   LONG-TERM SUPPRESSION OF RECURRENT GENITAL HERPES WITH ACYCLOVIR - A 5-YEAR BENCHMARK [J].
GOLDBERG, LH ;
KAUFMAN, R ;
KURTZ, TO ;
CONANT, MA ;
ERON, LJ ;
BATENHORST, RL ;
BOONE, GS .
ARCHIVES OF DERMATOLOGY, 1993, 129 (05) :582-587
[5]   PERIPHERAL EDEMA AND ORAL ACYCLOVIR [J].
HISLER, BM ;
DANESHVAR, SA ;
ARONSON, PJ ;
HASHIMOTO, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (05) :1142-1143
[6]  
LITT JZ, 1997, DRUG ERUPTION REFERE, P6
[7]  
MEDINA S, 1991, INT J DERMATOL, V30, P305
[8]   ACYCLOVIR - AN UPDATED REVIEW OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY [J].
OBRIEN, JJ ;
CAMPOLIRICHARDS, DM .
DRUGS, 1989, 37 (03) :233-309
[9]   ACYCLOVIR - A REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY [J].
RICHARDS, DM ;
CARMINE, AA ;
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1983, 26 (05) :378-438
[10]  
ROBINSON GE, 1985, GENITOURIN MED, V61, P62